… synthesis methods used to produce chitosan nanoparticles and nanostructures, such as ionic
… , we review drug delivery applications of chitosan nanoparticles, including for ocular, oral, …

… and optimize the chitosan (CS)-coated poly(lactide-co-glycolic acid) (PLGA) nanoparticles
(NPs) of bevacizumab for sustained and effective delivery to posterior ocular tissues. NPs …

… Chitosan nanoparticles and nanocapsules have shown interesting properties and … carriers
across the ocular mucosa. Although chitosan nanoparticles reside on the ocular surface for a …

… ) and extend ocular retention, chitosan nanoparticles carrying … , antimicrobial activity, and
ocular irritancy. The average … study provides a valuable carrier for effective CAP delivery. …

… are the proven promising drug delivery vehicle in ocular applications … chitosan nanoparticle
as a new vehicle for the improvement of the delivery of the antibiotic ofloxacin to the ocular …

… chitosan nanoparticles has shown the interaction and prolonged residence time of chitosan
nanoparticles at the ocular … also been investigated for the treatment of ocular infections [14]…

… Thus, we develop non–invasive nanocarriers (CSNPs) for topical ocular delivery of LZ to
treat the increasing multi–drug–resistant eye infections. The CSNPs prolong the …

… Modified ocular drug delivery systems like ocular inserts and in-situ gelling systems, though
… that polymeric nanoparticles could serve as a best suited option in topical ocular delivery. …

… residence of the chitosan nanoparticles was enhanced when converted into an in situ gel
formulation. Further, the chitosan nanoparticles did not induce irritation of the ocular tissue. …

… The dissolution mechanism of chitosan nanoparticles is characterized by a triphasic pattern.
An initial burst release was recorded that followed by a slower release, during which the …